A CDMO Perspective on the Formulation of Complex Dosage Forms

A CDMO Perspective on the Formulation of Complex Dosage Forms

25 April, 2019
It is well recognized that many existing active pharmaceutical ingredients (API’s) and new chemical entities (NCE’s) are poorly water soluble and subsequently have low oral bioavailability if formulated in unmodified form. These compounds are also challenging to formulate for other routes of administration, especially parenteral.
Read More